Monoclonal antibodies in excess: A simple way to avoid immunogenicity in patients? - 04/09/15
This work has been funded with support from the French Higher Education and Research Ministry under the program “Investissements d'avenir” (grant agreement no. LabEx MAbImprove ANR-10-LABX-53-01). |
|
Disclosure of potential conflict of interest: H. Watier has received research support from the French Higher Education and Research Ministry under the program “Investissements d'avenir” (grant agreement no. LabEx MAbImprove ANR-10-LABX-53-01). B. Chaigne declares that he has no relevant conflicts of interest. |
Vol 136 - N° 3
P. 814-816 - septembre 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?